Yung-Hua Wang - Concepedia

Author

Yung-Hua Wang

University of California, San Francisco

Also Known As

Yung-Hua Wang, Yung-hua Wang

Publications

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco UCSF Helen Diller Family Comprehensive Cancer Center Skolkovo Institute of Science and Technology Centre National de la Recherche Scientifique Commissariat à l'Énergie Atomique et aux Énergies Alternatives

About

Yung-Hua Wang is an author at University of California, San Francisco specializing in medicine, engineering, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	190
2	Engineering	5	5	127
3	Health Sciences	1	1	20
4	Natural Sciences	1	1	44
5	Biochemistry	1	1	45

Yung-Hua Wang

Publications

989

Citations

H-Index

Page 1

	Year	Citations
APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia Michael S. Haney, Róbert Pálovics, Christy Munson, Nature	2024	389
Imaging PD-L1 Expression with ImmunoPET Charles Truillet, Hsueh Ling Janice Oh, Siok Ping Yeo, Bioconjugate Chemistry	2017	126
In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET Ning Zhao, Conner Bardine, André Luiz Lourenço, ACS Central Science	2021	57
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies Ning Zhao, Yangjie Huang, Yung-Hua Wang, Journal of Nuclear Medicine	2020	54
Measuring Dynamic Changes in the Labile Iron Pool in Vivo with a Reactivity-Based Probe for Positron Emission Tomography Ryan K. Muir, Ning Zhao, Junnian Wei, ACS Central Science EngineeringOncologic ImagingMicroscopyPet-mriRedox Biology	2019	45
A Preclinical Assessment of <sup>89</sup>Zr-atezolizumab Identifies a Requirement for Carrier Added Formulations Not Observed with <sup>89</sup>Zr-C4 Anna Moroz, Chia‐Yin Lee, Yung-Hua Wang, Bioconjugate Chemistry Modest Pd-l1 ExpressionImmunologyImmunoeditingImmunotherapeuticsChemistry	2018	44
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers Shion A. Lim, Jie Zhou, Alexander J. Martinko, Journal of Clinical Investigation Ras-driven CancersTumor BiologyProtein FunctionProteolytic NeoepitopeMedicine	2022	39
Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET Sinan Wang, Jun Li, Jun Hua, Clinical Cancer Research	2020	37
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer Anna Moroz, Yung-Hua Wang, Jeremy Sharib, Clinical Cancer Research	2020	36
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease Ning Zhao, Shalini Chopra, Kai Trepka, Clinical Cancer Research	2022	29

Page 1